Faisal Saiful, MD
Interventional Cardiology · Klamath Falls, ORNPI 1205081494
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.1%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Medtronic at 35.3% of the total. Reporting peaked in 2020 at $12,789 and has fallen 72.0% since, to $3,582 in 2025.
Across 643 payments — averaging $51.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Edwards Lifesciences$7K
- Abbott$4K
- Boston Scientific$1K
- AOP Health US, LLC$1K
- Novartis$618
- plus $7K from 32 others
What the payments were for
- Grants$10,50032%
- Travel & lodging$3,64111%
- Food & beverage$18,94957%
- Education$860%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 27 | $11,695 |
| Edwards Lifesciences | 156 | $7,368 |
| Abbott | 66 | $4,232 |
| Boston Scientific | 23 | $1,170 |
| AOP Health US, LLC | 1 | $1,046 |
| Novartis | 40 | $618 |
| Shockwave Medical, Inc | 25 | $597 |
| E.r. Squibb & Sons, L.L.C. | 36 | $537 |
| Cardiovascular Systems Inc. | 10 | $509 |
| AstraZeneca | 25 | $505 |
| Pfizer | 26 | $472 |
| Amgen | 23 | $460 |
| Johnson & Johnson | 27 | $439 |
| Abiomed | 12 | $413 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $387 |
| Boehringer Ingelheim | 17 | $346 |
| Philips North America LLC | 14 | $339 |
| Biotronik Inc. | 12 | $244 |
| Terumo Medical Corporation | 10 | $243 |
| Merck | 13 | $221 |
| Bard Peripheral Vascular, Inc. | 9 | $210 |
| Chiesi USA, Inc. | 8 | $191 |
| Cook Medical LLC | 2 | $141 |
| Bridgebio Pharma, Inc. | 2 | $139 |
| Bayer | 4 | $85 |
| Cardiva Medical, Inc. | 3 | $85 |
| Penumbra, Inc. | 4 | $81 |
| Lexicon Pharmaceuticals, Inc. | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 4 | $64 |
| Actelion Pharmaceuticals US, Inc. | 4 | $61 |
| Heartflow, Inc. | 2 | $60 |
| CSL Behring | 2 | $49 |
| Amarin Pharma, Inc. | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rapiblyk$2,092
- TRICLIP$1,000
- MitraClip$896
- Diamondback Peripheral$539
- WATCHMAN Access System$532
- CoreValve Evolut$368
- SAPIEN 3 Ultra RESILIA$336
- Diamondback Coronary$289
- Impella$217
- Avalus$146
- Perclose ProGlide suture mediated closure system$130
- CAMZYOS$125
- Zilver PTX$125
- Attruby$123
- FARXIGA$117
- ONYX FRONTIER$111
How this compares
$33,176 in reported general payments places this provider in the 75th percentile of 68 interventional cardiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 199 | $228,902 |
| EntrestoSacubitril/Valsartan | 104 | $107,033 |
| XareltoRivaroxaban | 62 | $62,689 |
| JardianceEmpagliflozin | 18 | $27,519 |
| MultaqDronedarone Hcl | 12 | $13,466 |
| BrilintaTicagrelor | 16 | $12,637 |
| OzempicSemaglutide | 11 | $11,256 |
| Amiodarone Hcl | 47 | $4,962 |
| Metoprolol Succinate | 172 | $2,890 |
| Bisoprolol Fumarate | 71 | $1,976 |
| Rosuvastatin Calcium | 81 | $1,869 |
| Losartan Potassium | 155 | $1,523 |
| Atorvastatin Calcium | 102 | $1,279 |
| ClopidogrelClopidogrel Bisulfate | 138 | $1,235 |
| Torsemide | 40 | $987 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $472 | $228,902199 claims |
| NovartisEntresto | $618 | $107,033104 claims |
| Johnson & JohnsonXarelto | $439 | $62,68962 claims |
| Boehringer IngelheimJardiance | $346 | $27,51918 claims |
| Sanofi-aventis U.S. LLCMultaq | $17 | $13,46612 claims |
| AstraZenecaBrilinta | $505 | $12,63716 claims |
| Novo NordiskOzempic | $17 | $11,25611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 68 interventional cardiology providers in Oregon.
Other interventional cardiology in Klamath Falls
- Rastislav KucinskyKlamath Falls$4K
- George KubacKlamath Falls$4K
- Ami PatelKlamath Falls$3K
- Jason WollmuthPortland$749K
- Saurabh GuptaBend$550K
- Ethan KorngoldPortland$407K
- Amish DesaiPortland$186K
- Harsh GolwalaPortland$105K
- Brandon JonesPortland$101K
- Sudeshna BanerjeeSpringfield$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.